News & Trends - Medical Technology

Siemens COVID-19 antibody test to be delivered worldwide

Health Industry Hub | June 3, 2020 |
[Total: 1    Average: 4/5]

MedTech News: Siemens Healthineers is now shipping worldwide its laboratory-based total antibody test to detect the presence of SARS-CoV-2 IgM and IgG antibodies in blood.

The test received the CE mark and data has demonstrated 100% sensitivity and 99.8% specificity. The total antibody test allows for identification of patients who have developed an adaptive immune response, which indicates recent infection or prior exposure.

The company is prepared to ramp up production as the pandemic evolves with capacity exceeding 50 million tests per month across its platforms starting in June.

The antibody test is now available on the Atellica Solution immunoassay analyser, which can run up to 440 tests per hour and enables a result in just 10 minutes. By detecting both IgM and IgG antibodies, the test provides a clearer clinical picture over a longer period of time as the disease progresses.

Register & join 22,000+ industry professionals in reading the latest industry news & engaging content from Health Industry Hub, the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

Importantly, the test detects antibodies to a key protein on the surface of the SARS-CoV-2 virus—a spike protein, which binds the virus to cells with a distinct human receptor found in lungs, heart, multiple organs and blood vessels.

“Not all antibody tests are created equal. A high-quality test that targets the right protein and is highly scalable is essential for antibody testing to help ensure we effectively manage the threat of COVID-19,” said Deepak Nath, PhD, President, Laboratory Diagnostics, Siemens Healthineers. “Siemens Healthineers sought to provide a highly accurate antibody test that could reach millions of people to address the current need for identifying immune response, and also for delivering long-term value as we look toward immunity and vaccination.”

The total antibody test also is available on the company’s expansive installed base of ADVIA Centaur XP and XPT analyzers, which can test up to 240 samples per hour, with a result in 18 minutes. Comparable tests for Siemens Healthineers Dimension Vista and Dimension EXL systems also are being pursued, with a view to realise clinical reach. The company intends to develop an IgG test to provide flexibility for testing needs as the pandemic evolves.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Pharmaceuticals

Pharma News - 20 biopharmaceutical companies enter a ground-breaking partnership - AMR Action Fund

20 biopharmaceutical companies enter a ground-breaking partnership

Health Industry Hub | July 10, 2020 |

Please log in to Health Industry Hub to view this content in the ‘News & Trends’ menu.

Health Industry Hub is Australia’s ONLY one-stop-hub connecting Pharma, Biotech and MedTech industry professionals. Learn more.

More


Market Research & Insights

Market Research Pharma Biotech MedTech - Incredible breadth of Australia’s COVID-19 research: From vaccines to aircon filters

Incredible breadth of Australia’s COVID-19 research: From vaccines to aircon filters

Health Industry Hub | July 9, 2020 |

Market Research & Insights: Since the coronavirus hit Australia’s shores, health and medical researchers have been rapidly redeployed in unprecedented […]

More


Mentoring

Pharma Biotech Medtech Mentoring - Award-winning IMNIS program fosters collaboration and innovation between industry and academia

Award-winning IMNIS program fosters collaboration and innovation between industry and academia

Health Industry Hub | July 9, 2020 |

Mentoring: The Industry Mentoring Network in STEM (IMNIS) provides PhD student mentees an understanding of the industry sector, strengthen their […]

More


Communication

Communication Public Relations Pharma Biotech Medtech - The changing landscape of Pharma corporate communications - interview

The changing landscape of corporate communications in the Pharma industry

Health Industry Hub | July 8, 2020 |

COVID-19 has had a dramatic impact on the role and nature of healthcare communications, especially following the recent bushfire crisis […]

More